Acetylation of cyclin-dependent kinase 5 is mediated by GCN5

Juhyung Lee1, Nuri Yun1, Chiho Kim1

  • 1Department of Systems Biology, Yonsei University College of Life Science and Biotechnology, Seoul 120-749, Republic of Korea.

Insights

Acetylation is a newly discovered posttranslational modification for cyclin-dependent kinase 5 (CDK5). GCN5 enhances CDK5 acetylation at Lys33, potentially impacting kinase activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Cyclin-dependent kinase 5 (CDK5) is vital in neurodegenerative disease.
  • CDK5 activity is regulated by phosphorylation, S-nitrosylation, and activator binding.

Purpose of the Study:

  • To investigate acetylation as a novel posttranslational modification of CDK5.
  • To identify enzymes regulating CDK5 acetylation.

Main Methods:

  • Co-immunoprecipitation assays to confirm protein interactions.
  • Fluorescent localization studies for subcellular co-localization.
  • Liquid chromatography-mass spectrometry for identifying acetylation sites.

Main Results:

  • Acetylation enhances CDK5 modification within cells.
  • GCN5, a histone acetyltransferase, interacts with and enhances CDK5 acetylation.
  • CDK5 is acetylated at Lys33 in the ATP binding domain.
  • Lys33 is conserved across species and related kinases.

Conclusions:

  • Acetylation represents a new regulatory mechanism for CDK5.
  • GCN5-mediated acetylation of CDK5 at Lys33 may modulate its kinase activity by affecting ATP binding.

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.5K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.3K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
100.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

4.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K